Wang Gang, He Chen-Jun, Liang Xiao-Song, Zhou Yi-Fu, Chen Si-Hua
Department of Neurosurgery, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), 568 North Zhongxing Road, Shaoxing 312000, Zhejiang Province, PR China.
Department of Neurosurgery, Affiliated Hospital of Shaoxing University (Shaoxing Municipal Hospital), 999 South Zhongxing Road, Shaoxing 312000, Zhejiang Province, PR China.
Clin Chim Acta. 2020 Nov;510:111-116. doi: 10.1016/j.cca.2020.07.014. Epub 2020 Jul 10.
Substance P (SP) is implicated in brain inflammation. We clarified relationship between serum SP concentrations and functional outcome of acute intracerebral hemorrhage (ICH).
We quantified admission serum SP concentrations in 106 ICH patients. The primary outcome measure was a poor outcome at 90 days (modified Rankin Scale score ≥ 3) after onset.
Patients with a poor outcome compared with the rest had substantially higher serum SP concentrations. The area under the curve for serum SP concentrations with regard to discriminating a poor outcome was 0.795 (95% CI, 0.706 to 0.867). Serum SP concentrations >449 pg/ml predicted the risk of a poor outcome with 63.0% sensitivity and 78.9% specificity, and were independently associated with a poor outcome (odds ratio, 5.437; 95% CI, 2.156 to 13.715). There were the positive associations between serum SP concentrations, National Institutes of Health Stroke Scale score (r = 0.480), hematoma volume (r = 0.464) and serum C-reactive protein concentrations (r = 0.398).
Higher serum SP concentrations in the acute phase of ICH were intimately associated with aggravated inflammation response, rising severity and increased risk of a poor functional outcome, suggesting that serum SP could be an inflammatory prognostic factor for ICH.
P物质(SP)与脑部炎症有关。我们阐明了血清SP浓度与急性脑出血(ICH)功能结局之间的关系。
我们对106例ICH患者的入院血清SP浓度进行了定量分析。主要结局指标是发病后90天预后不良(改良Rankin量表评分≥3)。
与其他患者相比,预后不良的患者血清SP浓度显著更高。血清SP浓度用于区分预后不良的曲线下面积为0.795(95%CI,0.706至0.867)。血清SP浓度>449 pg/ml预测预后不良的风险,敏感性为63.0%,特异性为78.9%,且与预后不良独立相关(优势比,5.437;95%CI,2.156至13.715)。血清SP浓度与美国国立卫生研究院卒中量表评分(r = 0.480)、血肿体积(r = 0.464)和血清C反应蛋白浓度(r = 0.398)之间存在正相关。
ICH急性期血清SP浓度升高与炎症反应加重、病情严重程度增加及功能预后不良风险增加密切相关,提示血清SP可能是ICH的炎症预后因素。